Cas:286455-85-4 (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid CAS:286455-85-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid

Chemical Name:(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid
CAS.NO:286455-85-4
Synonyms:(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid
Molecular Formula:C15H21NO4S
Molecular Weight:311.39700
HS Code:2933990090

Physical and Chemical Properties:
Melting point:158-160ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:83.06000
Exact Mass:311.11900
LogP:3.24050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid Use and application,(2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid vendor After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. (2S)-1-(4-tert-butylphenyl)sulfonylpyrrolidine-2-carboxylic acid factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.